Evidence map›Paper›PMID 32032849›Full record

ArticleBioorganic chemistry2020

Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics.

Cheng-Peng Sun, Juan Zhang, Wen-Yu Zhao, Jing Yi, Jian-Kun Yan, Ya-Li Wang, Christophe Morisseau, Zhong-Bo Liu, Bruce D Hammock, Xiao-Chi Ma

Open access · greenAbstract read
In one paragraph

Article in Bioorganic chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. The Inhibition Activity of Natural Methoxyflavonoid fromInternational journal of molecular sciences · 2024
    Article
  3. Inhibitory Activity of NaturalPlants (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Journal of natural products · 2020
    Article
  13. Review
  14. Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Cheng-Peng SunCollege of Pharmacy, College (Institute) of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, Dalian Medical University, Dalian, China. Electronic address: suncp146@163.com.
Juan ZhangCollege of Pharmacy, College (Institute) of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, Dalian Medical University, Dalian, China; School of Life Science, Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, Liaoning Normal University, Dalian, China.
Wen-Yu ZhaoCollege of Pharmacy, College (Institute) of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, Dalian Medical University, Dalian, China.
Jing YiCollege of Pharmacy, College (Institute) of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, Dalian Medical University, Dalian, China.
Jian-Kun YanAnalysis Center of College of Science & Technology, Hebei Agricultural University, Cangzhou, Hebei, China.
Ya-Li WangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.
Christophe MorisseauDepartment of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA.
Zhong-Bo LiuSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China. Electronic address: 546265581@qq.com.
Bruce D HammockDepartment of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA. Electronic address: bdhammock@ucdavis.edu.
Xiao-Chi MaCollege of Pharmacy, College (Institute) of Integrative Medicine, The National & Local Joint Engineering Research Center for Drug Development of Neurodegenerative Disease, Dalian Medical University, Dalian, China.
Dalian Medical University · CNShenyang Pharmaceutical University · CNHebei Agricultural University · CNLiaoning Normal University · CNUC Davis Comprehensive Cancer CenterUniversity of California, Davis · US

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
Supplement for bioactive lipids as effectors and indicators of the deleterious effects of human healthR35ES030443 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MORISSEAU, CHRISTOPHE HP · 2019 to 2025
$5.8M
NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R35 ES030443
6 · The paper itself

Abstract

The inhibition of soluble epoxide hydrolase (sEH) is a promising therapeutic approach to treat inflammation and other disorders. In our present investigation on searching for sEH inhibitors from traditional Chinese medicines, we found that Alisma orientale displayed inhibition of sEH. We constructed a small library of protostane-type triterpenoids (1-25) isolated from A. orientale, and screened their inhibitory activities. Alismanin B (1), 11-deoxy-25-anhydro alisol E (4), 11-deoxy alisol B (5), and 25-O-ethyl alisol A (15) displayed concentration-dependently inhibitory activities against sEH with IC

Indexed as

AlismaEnzyme InhibitorsEpoxide HydrolasesHumansMolecular Docking SimulationMolecular Dynamics SimulationTriterpenesEnzyme InhibitorsEpoxide HydrolasesTriterpenesInhibition kineticsMolecular dynamics stimulationProtostane-type triterpenoidsSoluble epoxide hydrolase

Identifiers

PMID32032849
PMCPMC7233170
OpenAlexW3003456234

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.